Literature DB >> 14648568

Sickle red blood cells accumulate in tumor.

S L Brown1, J R Ewing, T N Nagaraja, P S Swerdlow, Y Cao, J D Fenstermacher, J H Kim.   

Abstract

The preferential accumulation of sickle blood cells in tumor vasculature is demonstrated noninvasively using MRI and sickle red blood cells loaded with Gd-DTPA and invasively by two other techniques. The distribution of red blood cells in rat brain tumors relative to normal brains were measured using three separate techniques: MRI of Gd-DTPA loaded cells, fluorescent microscopy detection of Oregon Green 488 fluorescence conjugated to a streptavidin-biotin complex that binds to red blood cell surface proteins, and autoradiography using a technetium (99m)Tc-labeling kit. Labeled red cells were infused intravenously in rats with brain tumors. Sickle cells preferentially accumulated in tumor relative to normal brain, with highest concentrations near the tumor / normal tissue boundary, whereas control normal red cells did not preferentially aggregate at the tumor periphery. This demonstrates the potential of sickle red blood cells to accumulate in the abnormal tumor vessel network, and the ability to detect their aggregation noninvasively and at high spatial resolution using MRI. The application of the noninvasive measurement of sickle cells for imaging tumor neovasculature, or as a delivery tool for therapy, requires further study. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14648568     DOI: 10.1002/mrm.10646

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  5 in total

Review 1.  Cell carriers for oncolytic viruses: Fed Ex for cancer therapy.

Authors:  Candice Willmon; Kevin Harrington; Timothy Kottke; Robin Prestwich; Alan Melcher; Richard Vile
Journal:  Mol Ther       Date:  2009-08-18       Impact factor: 11.454

Review 2.  Adverse events in cancer patients with sickle cell trait or disease: case reports.

Authors:  Helen Swede; Biree Andemariam; David I Gregorio; Beth A Jones; Dejana Braithwaite; Thomas E Rohan; Richard G Stevens
Journal:  Genet Med       Date:  2014-08-21       Impact factor: 8.822

3.  RRx-001 Increases Erythrocyte Preferential Adhesion to the Tumor Vasculature.

Authors:  Vinay P Jani; Robert Asaro; Bryan Oronsky; Pedro Cabrales
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

Review 4.  The quest for a better insight into physiology of fluids and barriers of the brain: the exemplary career of Joseph D. Fenstermacher.

Authors:  Adam Chodobski; Jean-François Ghersi-Egea; Charles Nicholson; Tavarekere N Nagaraja; Joanna Szmydynger-Chodobska
Journal:  Fluids Barriers CNS       Date:  2015-01-12

5.  Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response.

Authors:  David S Terman; Benjamin L Viglianti; Rahima Zennadi; Diane Fels; Richard J Boruta; Hong Yuan; Mathew R Dreher; Gerald Grant; Zahid N Rabbani; Ejung Moon; Lan Lan; Joseph Eble; Yiting Cao; Brian Sorg; Kathleen Ashcraft; Greg Palmer; Marilyn J Telen; Mark W Dewhirst
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.